Australian Clinical Labs : Establishment of Dividend Reinvestment Plan

Australian Clinical Labs Limited

ABN 94 645 711 128 Registered Office:

1868-1892Dandenong Road Clayton VIC 3168 Australia

clinicallabs.com.au

ESTABLISHMENT OF DIVIDEND REINVESTMENT PLAN

ASX Announcement

only24 February 2022

Australian Clinical Labs Limited (ASX: ACL) (ACL or Company) advises that it has established a Dividend Reinvestment Plan (DRP). The DRP provides eligible ACL shareholders with a convenient method of reinvesting all or part of their dividends in additional ACL shares.

useIn accordance with ASX Listing Rule 3.10.8, a copy of the terms of the DRP are attached. A copy of the terms of the DRP are also available at the ACL website Dividends - Australian Clinical Labs.

In accordance with ASX Listing Rule 3.17.1, attached are the additional following documents that will be sent to ACL shareholders:

1. a DRP highlights and frequently asked questions document;
2. a participation form; and
3. communications to shareholders regarding the implementation of the DRP.

ACL will advise when announcing any future dividend payments if the DRP will be operational.

- ENDS -

This announcement was authorised for release to ASX by the Company Secretary.

For further information regarding this announcement, please contact:

Investors	Governance
Davina Gunn	Eleanor Padman
Investor Relations	Company Secretary
personalEmail: [e-mail]	Email:[e-mail]
Phone: [phone]	Phone: [phone]
For
About Australian Clinical Labs

ACL is a leading Australian private provider of pathology services. Our 86 NATA accredited laboratories perform a diverse range of pathology tests each year for a range of clients including doctors, specialists, patients, hospitals and corporate clients. ACL is one of the largest private hospital pathology businesses nationally. ACL is focused on its mission of combining talented people, and medical and scientific leadership, with innovative thinking and technologies to empower decision making that saves and improves patients' lives.

Page 1 of 1

Australian Clinical Labs Limited ABN 94 645 711 128

For personal use only

Dividend Reinvestment Plan Rules

Australian Clinical Labs Limited (ACN 645 711 128)

Approved by the Board on 17 February 2022

For personal use only

Contents		Page
1	Defined terms and interpretation	1
		1.1	Definitions in the Dictionary	1
		1.2	Interpretation	1
2	Commencement	1
3	Eligibility to participate	1
		3.1	Invitation to participate	1
		3.2	Participation subject to the Rules	1
		3.3	Eligible Shareholders	1
		3.4	Board's discretion	2
		3.5	Shareholder's responsibility to obtain approvals	2
		3.6	Multiple holdings	2
		3.7	Broker clearing accounts, trustees and nominees	3
		3.8	US persons and estates	3
4	Application to participate and extent of participation	3
		4.1	Application to participate	3
		4.2	Term of participation	3
		4.3	Board's power	3
		4.4	Full Participation and Partial Participation	4
		4.5	Records	4
5	Minimum Participating Holding and Maximum Participating
		Holding	5
		5.1	Minimum Participating Holding	5
		5.2	Maximum Participating Holding	5
6	Shareholder's acknowledgments	5
7	Reinvestment of Dividends	7
		7.1	Application towards additional Shares	7
		7.2	Dividends not available for reinvestment	7
		7.3	DRP account and allocation of Shares	7

For personal use only

	7.4 Residual balance to be retained	7
	7.5 Residual balance to be paid out	7
	7.6 Allocation Price	8
8	Allocation of Shares	8
9	Underwriting	9
10	DRP statements	9
11	Variation or termination by the Participant	9
12	Reduction or termination by the Participant where no notice
	is given	10
13	Variation, suspension and termination of the DRP or these
	Rules by the Company	10
14	Cost to Participants	11
15	Applications and other notices	11
16	Taxation	12
17	General	12
	Dictionary	14

For personal use only

1. Defined terms and interpretation
2. 1. Definitions in the Dictionary
      A term or expression starting with a capital letter which is defined in the Dictionary in Schedule 1 (Dictionary) has the meaning given to it in the Dictionary.
   2. Interpretation
      The interpretation clause in Schedule 1 (Dictionary) sets out rules of interpretation for these Rules.
3. Commencement

The DRP and these Rules will commence operation on such date as the Board in its sole discretion determines.

3 Eligibility to participate

1. Invitation to participate
   The Company may from time to time invite Shareholders to participate in the DRP.
2. Participation subject to the Rules
   Participation in the DRP is subject to these Rules.
3. Eligible Shareholders
4. 1. Participation in the DRP:
   2. 1. is open to all Eligible Shareholders;
      2. is optional and voluntary;
      3. is not transferable; and
      4. may be varied or terminated at any time in accordance with rules 11 and 13.
   3. Subject to rule 3.4, an Eligible Shareholder is, in respect of a particular Dividend:
   4. 1. a Shareholder whose address in the Company's share register is at the Dividend Record Date in Australia or New Zealand, unless that person holds Shares only on behalf of another person who resides outside Australia or New Zealand and who would not themselves, if named in the Company's share register, be an Eligible Shareholder under rule 3.3(b)(ii); or
      2. any other Shareholder in respect of whom the Board is satisfied at the Dividend Record Date, or who has satisfied the Board at the Dividend Record Date, that:
      3. 1. the offer and issue or transfer of Shares under the DRP to that Shareholder is lawful and practicable in the jurisdiction in which they reside; and

page | 1